Vogelbruch M, Böcking A, Rütten A, Kapp A, Kiehl P
Department of Dermatology and Allergology, Hannover Medical University, Ricklinger Strasse 5, D-30449 Hannover, Germany.
Br J Dermatol. 2000 Apr;142(4):688-93. doi: 10.1046/j.1365-2133.2000.03413.x.
The histopathological differentiation between well-differentiated carcinomas and atypical adenomas of sweat gland origin may be difficult, even if immunohistochemical methods are used. Therefore, additional techniques may be helpful. We previously demonstrated that DNA image cytometry (ICM-DNA) can be useful in distinguishing between malignant and benign clear cell hidradenoma. In the present study, a larger series of sweat gland tumours, with a clear-cut diagnosis as malignant or benign on histopathological criteria, was examined by ICM-DNA. Enzymatic cell separation specimens were prepared from paraffin-embedded tissues of 18 sweat gland carcinomas (14 porocarcinomas, one classic eccrine adenocarcinoma, two microcystic adnexal carcinomas and one mostly ductal apocrine carcinoma) and 47 benign sweat gland tumours (three syringocystadenomas, five spiradenomas, 14 cylindromas, three syringomas, seven nodular hidradenomas, 10 cutaneous mixed tumours, four poromas and one apocrine hidrocystoma). Specimens were examined by ICM-DNA according to the current recommendations of the European Society for Analytical Cellular Pathology with the AutoCyte QUIC-DNA workstation using mesenchymal cells as an internal reference. DNA aneuploidy was detected by the stemline interpretation according to Böcking and/or at least three 5[c]-exceeding events. DNA aneuploidy was detected in 16 of 18 (89%) of the sweat gland carcinomas, but in none of the 47 adenomas. These results suggest that the detection of DNA aneuploidy in sweat gland tumours using ICM-DNA is a clear and specific indicator of prospective malignancy.
即使采用免疫组织化学方法,高分化汗腺癌与汗腺起源的非典型腺瘤之间的组织病理学鉴别也可能存在困难。因此,其他技术可能会有所帮助。我们之前证明,DNA图像细胞术(ICM-DNA)可用于区分恶性和良性透明细胞汗腺瘤。在本研究中,我们通过ICM-DNA对一系列更大的汗腺肿瘤进行了检查,这些肿瘤在组织病理学标准上具有明确的恶性或良性诊断。从18例汗腺癌(14例汗孔癌、1例经典小汗腺腺癌、2例微囊性附属器癌和1例主要为导管大汗腺癌)和47例良性汗腺肿瘤(3例汗腺囊腺瘤、5例螺旋腺瘤、14例圆柱瘤、3例汗管瘤、7例结节状汗腺瘤、10例皮肤混合瘤、4例汗孔瘤和1例大汗腺囊瘤)的石蜡包埋组织中制备酶解细胞分离标本。根据欧洲分析细胞病理学学会的当前建议,使用AutoCyte QUIC-DNA工作站,以间充质细胞作为内部参考,通过ICM-DNA对标本进行检查。根据Böcking的方法通过主干线解释和/或至少三个5[c]超过事件来检测DNA非整倍体。在18例汗腺癌中有16例(89%)检测到DNA非整倍体,但在47例腺瘤中均未检测到。这些结果表明,使用ICM-DNA检测汗腺肿瘤中的DNA非整倍体是潜在恶性肿瘤的一个明确且特异的指标。